Evaluation of Long-term Outcomes and Toxicity after Stereotactic Phosphorus-32 Based Intracavitary Brachytherapy in Patients with Cystic Craniopharyngioma

Phosphorus-32-based interstitial brachytherapy has an established role as a minimally invasive treatment modality for patients with cystic craniopharyngioma. However, reporting on long-term outcomes with toxicity profiles for large cohorts is lacking in the literature. The purpose of this study is therefore to evaluate the long-term visual, endocrine and neurocognitive function in what is the largest patient series having received this treatment to date.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Source Type: research